Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 527.00
Bid: 522.00
Ask: 530.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.533%)
Open: 527.00
High: 527.00
Low: 527.00
Prev. Close: 527.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

16 May 2024 07:00

RNS Number : 6258O
Conduit Holdings Limited
16 May 2024
 

Pembroke, Bermuda - 16 May 2024

Conduit Holdings Limited

("CHL" LSE ticker: CRE)

Results of 2024 AGM

Conduit Holdings Limited announces the result of voting on the resolutions at its 2024 Annual General Meeting ("AGM") held on Wednesday 15 May 2024. The meeting considered the 18 resolutions as set out in the AGM Notice dated 12 April 2024.

Each of the resolutions was duly passed by the required majority. Resolutions 1 to 15 were passed as ordinary resolutions. Resolutions 16, 17 and 18 were passed as special resolutions. The total number of votes received for each resolution is set out below.

A copy of the special resolutions passed will be submitted to the National Storage Mechanism and available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The total voting rights in CHL on 15 May 2024 was 165,239,997.

Description

Votes For

% Votes Cast For

Votes Against

% Votes Cast Against

Votes Withheld

Total Votes Cast (excl. Votes Withheld)

% of Issued Share Capital voted

1. To receive the Company's audited consolidated financial statements for the financial period ended 31 December 2023 and the reports of the Directors and the Auditors thereon (the "Annual Report and Accounts").

127,167,576

100.00

0

0.00

178,046

127,167,576

76.96

2. To approve the Directors' Remuneration Policy as set out in the Annual Report and Accounts for the year ended 31 December 2023

96,719,933

81.77

21,559,064

18.23

9,066,625

118,278,997

58.53

3.To approve the annual report on remuneration as set out in the Annual Report and Accounts for the year ended 31 December 2023

125,716,041

98.72

1,629,581

1.28

0

127,345,622

76.08

4. To approve the rules of the Company's 2023 Long Term Incentive Plan produced to this AGM and initialled by the Chairman

99,252,895

83.91

19,026,102

16.09

9,066,625

118,278,997

60.07

5.To re-elect Neil Eckert as a Director of the Company.

125,436,389

98.50

1,909,233

1.50

0

127,345,622

75.91

6. To re-elect Trevor Carvey as a Director of the Company.

127,047,316

99.77

298,306

0.23

0

127,345,622

76.89

7. To re-elect Elaine Whelan as a Director of the Company.

126,702,993

99.50

642,629

0.50

0

127,345,622

76.68

8. To re-elect Michelle Seymour Smith as a Director of the Company.

127,149,876

99.85

195,746

0.15

0

127,345,622

76.95

9. To re-elect Malcolm Furbert as a Director of the Company.

127,033,366

99.75

312,256

0.25

0

127,345,622

76.88

10. To re-elect Elizabeth Murphy as a Director of the Company.

127,149,876

99.85

195,746

0.15

0

127,345,622

76.95

11. To re-elect Ken Randall as a Director of the Company.

125,550,558

98.59

1,795,064

1.41

0

127,345,622

75.98

12. To elect Rebecca Shelley as a Director of the Company

126,103,395

99.02

1,242,227

0.98

0

127,345,622

76.32

13. To re-appoint KPMG Audit Limited as auditors of the Company to hold office until the conclusion of the next general meeting of the Company at which accounts are laid.

127,345,622

100.00

0

0.00

0

127,345,622

77.07

14. To authorise the Directors to determine the remuneration of the auditors.

127,345,622

100.00

0

0.00

0

127,345,622

77.07

15. Directors' Authority to Allot Shares, as detailed in the Notice of Meeting.

126,144,437

99.06

1,201,185

0.94

0

127,345,622

76.34

SPECIAL RESOLUTIONS

 

 

 

 

 

 

 

16. Disapplication of Pre-emption Rights - 10% unrestricted as detailed in the Notice of Meeting.

125,372,496

98.45

1,973,126

1.55

0

127,345,622

75.87

17. Disapplication of Pre-emption Rights - 10% for acquisition or a specified capital investment as detailed in the Notice of Meeting.

120,860,325

94.91

6,485,297

5.09

0

127,345,622

73.14

18. To authorise the purchase of own Common Shares as detailed in the Notice of Meeting.

125,643,925

98.86

1,450,000

1.14

251,697

127,093,925

76.04

Media contacts

H/Advisors Maitland - Vikki Kosmalska / Genevieve Ryan

+44 (0) 207 379 5151

conduitre@h-advisors.global

Investor relations and other enquiries:

info@conduitreinsurance.com

Panmure Gordon (Joint Corporate Broker)

+44 (0) 207 886 2500

Berenberg (Joint Corporate Broker)

+44 (0) 203 207 7800

Peel Hunt (Joint Corporate Broker)

+44 (0) 207 418 8900

About Conduit Re

Conduit Re is a pure-play Bermuda-based reinsurance business with global reach. Conduit Reinsurance Limited is licensed by the Bermuda Monetary Authority as a Class 4 insurer. A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of a- (Excellent) to Conduit Reinsurance Limited. The outlook assigned to these ratings is stable.

Conduit Holdings Limited is the ultimate parent of Conduit Reinsurance Limited and is listed on the London Stock Exchange (ticker: CRE). References to "Conduit" include Conduit Holdings Limited and all of its subsidiary companies.

Learn more about Conduit Re:

Website: https://conduitreinsurance.com/

LinkedIn: https://www.linkedin.com/company/conduit-re

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFAFAIELSEDI
Date   Source Headline
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.